| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/18/2009 | EP1725578B1 A novel potassium channel modulator peptide |
| 02/18/2009 | EP1629000B1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 02/18/2009 | EP1366063B1 Inhibitors of lyn-associated signal transduction (last) and the use thereof in the treatment of prostate cancer |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | CN101370820A Compounds for the inhibition of apoptosis |
| 02/18/2009 | CN101370517A Peptide derived from hepatitis C virus |
| 02/18/2009 | CN101367868A Human Fc<gamma>R II linear ligand binding epitope |
| 02/18/2009 | CN101367867A Polypeptide for specificity detection of tubercle bacillus infection contamination, method and reagent kit thereof |
| 02/18/2009 | CN101367866A Crucial active peptide segment with immunosuppression function in early pregnancy factor |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/18/2009 | CN100462367C Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 02/18/2009 | CN100462366C Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491795 Neuropeptides and their use for pest control |
| 02/17/2009 | US7491703 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 02/17/2009 | US7491702 X1-Ser-Met-Arg-Glu-Arg-X2 in which X1 and X2 are up to 30 amino acid residues and the formula represents a reverse-order sequence corresponding to amino acid residues 332 to 328 of human APP and from zero to 30 successive amino acid residues |
| 02/17/2009 | US7491701 Peptides that bind to HSP90 proteins |
| 02/17/2009 | US7491690 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 02/17/2009 | US7491689 Compositions comprising the biologically active peptide YSL |
| 02/17/2009 | CA2325983C Drug delivery of proteins from polymeric blends |
| 02/12/2009 | WO2009021077A2 Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same |
| 02/12/2009 | WO2009019524A1 Genes and proteins for the biosynthesis of the lantibiotic 107891 |
| 02/12/2009 | WO2008145603A3 Pharmaceutical compositions comprising telomerase, and uses thereof |
| 02/12/2009 | WO2008100481A3 Lung cancer-targeted peptides and applications thereof |
| 02/12/2009 | US20090043076 Modified interferon beta with reduced immunogenicity |
| 02/12/2009 | US20090043074 Use of Ghrelin Splice Variant for Treating Cachexia and/or Anorexia and/or Anorexia-Cachexia and/or Malnutrition and/or Lipodystrophy and/or Muscle Wasting and/or Appetite-Stimulation |
| 02/12/2009 | US20090043073 Alpha-fetoprotein peptides and uses for imaging |
| 02/12/2009 | US20090042805 Peptides Useful As Dual Caspase-2/-6 Inhibitors And Their Biological Applications |
| 02/12/2009 | US20090042804 Novel peptide amphiphiles having improved solubility and methods of using same |
| 02/12/2009 | US20090042803 Inhibitors of protein kinases and uses thereof |
| 02/12/2009 | US20090042802 Compounds and peptides that bind the kgf receptor |
| 02/12/2009 | US20090042799 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 02/12/2009 | US20090042783 Apo e analogs and methods for their use |
| 02/12/2009 | US20090042235 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/12/2009 | US20090042231 Fret protease assays for clostridial toxins |
| 02/12/2009 | US20090042220 Kit comprising epitope specific immunoglobulin for use in diagnosis/prognosis of bone disorders; Antiarthritic agents; screenning for osteoarthritis |
| 02/12/2009 | US20090042213 Methods and compositions for detecting thyroglobulin in a biological sample |
| 02/12/2009 | US20090042212 Detection of primary infections with pathogens |
| 02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
| 02/12/2009 | US20090041794 Identification of Hla-A2-Presented T-Cell Epitopes Derived from the Oncofoetal Antigen-Immature Laminin Receptor Protein and Uses Thereof |
| 02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
| 02/12/2009 | US20090041732 Survivin Peptides As Cancer Vaccines |
| 02/12/2009 | DE102007036128A1 Antibiotische Peptide Antimicrobial peptides |
| 02/12/2009 | CA2695487A1 Genes and proteins for the biosynthesis of the lantibiotic 107891 |
| 02/12/2009 | CA2663580A1 Bioactive peptides and method of using same |
| 02/11/2009 | EP2022505A2 GLP-1, exendin-4, peptide analogs and uses thereof |
| 02/11/2009 | EP2021500A2 Selective modulation of receptor signalling |
| 02/11/2009 | EP2021364A1 Improved antimicrobial peptides |
| 02/11/2009 | EP2021355A1 Method of polymyxin b recovery from fermentation broth |
| 02/11/2009 | EP2021354A2 N-terminally modified glp-1 receptor modulators |
| 02/11/2009 | EP2021015A2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 02/11/2009 | EP1458747B1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 02/11/2009 | EP1259536B1 Methods of peptide preparation |
| 02/11/2009 | CN101362797A Thrombopoietin mimic peptide, preparation and application thereof |
| 02/11/2009 | CN101362796A B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof |
| 02/11/2009 | CN101362795A B cell epitope of epididymal protease inhibitor and antigen peptides containing thereof |
| 02/11/2009 | CN101362794A B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof |
| 02/11/2009 | CN101361969A Therapeutic hepatitis b vaccine and preparation method and use thereof |
| 02/10/2009 | US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof |
| 02/10/2009 | US7488792 Peptides; antitumor agents; anticancer agents |
| 02/10/2009 | US7488718 Synthetic HLA binding peptide analogues and uses thereof |
| 02/10/2009 | US7488717 Methods of inhibiting chemokine binding to chemokine receptors |
| 02/10/2009 | US7488713 Cancer treatment using C-type natriuretic peptides |
| 02/10/2009 | US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 02/05/2009 | WO2009017154A1 Method for producing peptide |
| 02/05/2009 | WO2009015843A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | WO2008140602A3 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN |
| 02/05/2009 | WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 02/05/2009 | WO2008100482A3 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/05/2009 | US20090036648 EGVI Endoglucanase and Nucleic Acids Encoding the Same |
| 02/05/2009 | US20090036383 Compositions and methods for promoting lipid mobilization in humans |
| 02/05/2009 | US20090036363 Peptides as cell penetrating carriers |
| 02/05/2009 | US20090036349 Methods and Compositions Related to Targeting Wounds, Regenerating Tissue, and Tumors |
| 02/05/2009 | US20090035359 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 02/05/2009 | US20090035317 Peptides binding to vascular endothelial growth factor |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035215 Radiofluorination |
| 02/05/2009 | CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2694808A1 Novel immunotherapy against neuronal and brain tumors |
| 02/05/2009 | CA2694542A1 Method for producing peptide |
| 02/04/2009 | EP2020417A1 Prostasin partial peptide and anti-prostasin antibody |
| 02/04/2009 | CN101360824A Lipopolysaccharide- or lipid A-binder, and novel peptide |
| 02/04/2009 | CN101357945A Synthetic peptide coupling antigen and reagent for testing porcine circovurus type 2 specific antibody |
| 02/04/2009 | CN101357937A Method for synthesizing atosiban acetate from solid phase polypeptide |
| 02/04/2009 | CN101357936A Method for synthesizing triptorelin from solid phase polypeptide |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/03/2009 | US7485777 Introducing nucleotide sequence into a plant cell encoding a variant of algae protoporphyrinogen IX oxidase that lacks the FAD binding sequence; nucleotide sequence is expressed and plant cell is regenerated into transgenic plant; transformation |
| 02/03/2009 | US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 02/03/2009 | US7485618 FGF-5 supported and binding peptides |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | CA2423916C Compounds with a branched linker |
| 01/29/2009 | WO2009015087A2 Compositions and methods for treatment of trauma |
| 01/29/2009 | WO2009014450A1 Novel peptides with anti-tumor activity |
| 01/29/2009 | WO2009013262A1 Antibiotic peptides |
| 01/29/2009 | WO2008128064A9 Truncated analogs of peptide and polypeptide therapeutics |
| 01/29/2009 | WO2008070049A3 Peptide and treatment for hiv-1 infection |
| 01/29/2009 | US20090030181 Peptides for Inhibiting MDM2 Function |
| 01/29/2009 | US20090030180 Hyaluronic Acid Binding Peptides Enhance Host Defense Against Pathogenic Bacteria |
| 01/29/2009 | US20090029924 Targeting Host Proteinases as a Therapeutic Strategy Against Viral and Bacterial Pathogens |